Intelligent Investment
Paris Market
Global Life Sciences Atlas
April 11, 2025 5 Minute Read
Overview
- Paris is at the epicenter of the French life sciences cluster, benefitting from an influx of government and private funding to support healthcare initiatives.
- One of the emerging clusters is the Paris-Saclay Cancer Cluster (PSCC), which was created in 2022 by Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi.
- The life sciences real estate market remains undersupplied, with only 2.9 million sq. ft. of existing purpose-built lab/R&D spaces in the Paris region (excluding owner-occupier spaces). Due to the lack of immediate availability, some take-up occurred in light industrial stock, and some tenants/landlords are converting such premises into lab/R&D spaces. The future development pipeline will, however, ease this position in 2025 and beyond.
- The effects of COVID-19 propelled a surge in venture capital investments in 2021. Subsequent funding momentum continued through 2023, but trailed off in 2024.
- The broader growth trend in venture capital investments reflects the strong fundamentals and the growing attractiveness of the Paris life sciences ecosystem. The long-term strategic vision of President Macron’s €7.5 billion Health Innovation Plan 2030 will likely make Paris more attractive to investors.
Submarkets
Life Sciences Venture Capital Investment Trends
Figure 1: Life Sciences Venture Capital Funding
Life Sciences Market Stats
Figure 2: Inventory Lab/R&D
Development Pipeline or Activity
Figure 3: Life Sciences Development Pipeline (sq.ft.)
- AGS Therapeutics
- Cellvax
- Eurofins
- Immutep
- Sanofi
- Safran
- Servier
- Stilla
- Svar
- Theranovir
- CNRS
- Gustave Roussy
- INRIA
- IPPG Institute
- La Pitié Salpêtrière Hospital
- Paris Saclay Hospital
- Paris-Saclay University
- Polytechnique
- South Île-de-France Medical Center (CHSF)
- University of Évry-Paris-Saclay
Global Life Science Markets
-
Cambridge boasts one of Europe’s most advanced life sciences hubs.
-
The Leiden Bio Science Park is the Netherlands’ main life sciences cluster due to the strong pharma and healthcare presence and close proximity to Amsterdam and Schiphol Airport.
-
London has all the elements of a strong global life sciences hub, with three of the world's leading universities for biomedical sciences—UCL, King’s College and Imperial College—located within the city.